Cognition Disorders  >>  GSK1034702  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK1034702 / GSK
NCT00937846: Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study

Completed
1
4
Europe
GSK1034702
GlaxoSmithKline
Cognitive Disorders
08/09
08/09
NCT00950586: Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702

Completed
1
48
Europe
GSK1043702, Dextromethorphan, Placebo
GlaxoSmithKline
Cognitive Disorders
12/09
12/09

Download Options